CATHATE 1.25 Milligram Tablets
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
19-04-2024
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
ESTROGENS CONJUGATED
Inapatikana kutoka:
John Wyeth & Brother Limited
INN (Jina la Kimataifa):
ESTROGENS CONJUGATED
Kipimo:
1.25 Milligram
Dawa fomu:
Tablets
Idhini hali ya:
Withdrawn
Idhini ya tarehe:
2007-10-05
Tabia za bidhaa
IRISH MEDICINES BOARD ACT 1995
MEDICINAL PRODUCTS(LICENSING AND SALE)REGULATIONS, 1998
(S.I. NO.142 OF 1998)
PA0022/068/002
Case No: 2026843
The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to
JOHN WYETH & BROTHER LIMITED
HUNTERCOMBE LANE SOUTH, TAPLOW, MAIDENHEAD, BERKSHIRE SL6 0PH, UNITED KINGDOM
an authorisation, subject to the provisions of the said Regulations, in respect of the product
CATHATE 1.25 MILLIGRAM TABLETS
The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as
may be specified in the said Regulations as listed on the reverse of this document.
This authorisation, unless previously revoked, shall continue in force from 24/11/2006 until 18/09/2010.
Signed on behalf of the Irish Medicines Board this
________________
A person authorised in that behalf by the said Board.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 25/11/2006_
_CRN 2026843_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Cathate* Tablets 1.25mg Coated Tablet
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Cathate tablets contain 1.25 mg Conjugated Estrogens.
For excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Coated tablet
A white coloured, oval coated tablet printed '1.25' in black.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Cathate is indicated for hormone replacement therapy (HRT) for estrogen deficiency symptoms in menopausal and
postmenopausal women.
Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or
contraindicated for, other medicinal products appro
Soma hati kamili
